In addition, inhibition of MLK3 activity with the MLK3 inhibitors URMC099 and CEP1347 resulted in a decrease in cell proliferation and a cell cycle arrest in SKOV3, TOV112D, and HEY ovarian cancer cells. Here, MAP3K11 is linked to ovarian carcinoma.